Aoyama Zaisan Networks Company,Limited Logo

Aoyama Zaisan Networks Company,Limited

Consulting on inheritance and business succession for individuals and corporations.

8929 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区赤坂八丁目4番14号青山タワープレイス3階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Aoyama Zaisan Networks Company, Limited is a Japanese consulting firm specializing in comprehensive property and asset management solutions. The company primarily offers two types of services: inheritance consulting for individual asset owners and business succession consulting for corporations. It leverages its expertise in real estate, financial products, and related services to provide tailored solutions for asset transfer, maintenance, and operations. The firm's service portfolio also includes real estate solutions and property investment support in the USA.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-07 08:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-08-07 08:31
Interim Report
半期報告書-第35期(2025/01/01-2025/12/31)
Japanese 201.7 KB
2025-06-11 06:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.3 KB
2025-05-09 05:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-04-07 03:24
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-03-27 07:51
Registration Form
確認書
Japanese 8.2 KB
2025-03-27 07:51
Governance Information
内部統制報告書-第34期(2024/01/01-2024/12/31)
Japanese 22.0 KB
2025-03-27 07:50
Annual Report
有価証券報告書-第34期(2024/01/01-2024/12/31)
Japanese 2.0 MB
2025-03-27 07:46
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-03-10 08:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-02-10 07:56
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-01-15 08:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2024-12-12 06:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.9 KB
2024-11-14 08:01
Regulatory News Service
臨時報告書
Japanese 64.0 KB
2024-08-08 08:03
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all Aoyama Zaisan Networks Company,Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Aoyama Zaisan Networks Company,Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan 4326
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France ALINT
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan 7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan 9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea 287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea 216400
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden ISOFOL

Talk to a Data Expert

Have a question? We'll get back to you promptly.